Ibogaine Treatment Las Vegas, NV: Cost, Legality, Clinics

Ibogaine Treatment Las Vegas, Nevada: Vetted Clinics for Clark County Patients

Nevada came closer than most states to allowing supervised ibogaine treatment — and then it did not happen. A 2025 bill that would have let veterans and first responders receive ibogaine at state-approved clinics passed its committee, was sent to Ways and Means, and quietly died there. This page explains exactly what happened and what it means for you, because the alternative is being sold a timeline that does not exist.

Ibogaine remains a Schedule I substance under federal law, and Nevada has no state exemption. For Clark County patients who need treatment now, the path leads to licensed, medically supervised clinics in Mexico.

Psychedelic Connect is a treatment advisory service. We connect Las Vegas and Clark County patients with vetted ibogaine clinics in Mexico. Call (866) 435-7057 or request a consultation to speak with a patient coordinator.

For a full picture of what to budget, see what ibogaine treatment costs.

Can You Get Ibogaine Treatment in Las Vegas?

No. Ibogaine is Schedule I under federal law and there is no licensed ibogaine clinic anywhere in Nevada. The 2025 bill that would have created a supervised pilot programme died in committee. Legal, medically supervised treatment means travelling to Mexico.

If a Las Vegas provider advertises ibogaine, treat that as a warning rather than a convenience. Ibogaine affects cardiac rhythm, and the deaths associated with it have overwhelmingly occurred outside medical settings where nobody screened the patient or monitored the heart.

What Happened to Nevada’s Ibogaine Bill?

Assembly Bill 378 (2025) would have let veterans and first responders aged 21 and over receive psilocybin, DMT, ibogaine or mescaline at state-approved clinics. It cleared its policy committee, was re-referred to Ways and Means, and died there with no final passage vote.

The record from the Nevada Legislature is unambiguous:

• 10 March 2025 — introduced, referred to Assembly Health and Human Services.
• 26 March 2025 — heard in committee.
• 11–15 April 2025 — work session; committee reported it out “amend, and do pass as amended.”
• 16 April 2025 — read a second time, amended (Amendment 446), taken from the General File and re-referred to the Committee on Ways and Means.
• 3 June 2025 — “(No further action taken.)”

Final passage votes: none recorded. A bill re-referred to a money committee that then takes no further action before the session ends has died, regardless of how well it did earlier. AB 378 never became law, and Nevada has no ibogaine programme.

Source: Nevada Legislature, NELIS bill record for AB378, 83rd Session (2025), accessed 11 September 2026.

Could Nevada Legalise It Soon?

Not before 2027, as a matter of arithmetic. Nevada’s legislature meets in regular session only in odd-numbered years. There was no regular 2026 session, and the next one convenes in February 2027 — so no new Nevada law on ibogaine can pass before then.

This is worth knowing precisely because it is the sort of thing a salesperson will blur. Nobody can enrol you in a Nevada programme, and nobody can honestly tell you one is months away. If a bill is reintroduced in 2027 and passes, a pilot programme would still need regulations, approved clinics and approved practitioners after that.

Does Ibogaine Fit Clark County’s Overdose Picture?

Partly, and Las Vegas has a complication worth being honest about. Ibogaine’s strongest evidence is in opioid dependence — but in Southern Nevada, opioid use and stimulant use overwhelmingly travel together, and ibogaine’s evidence for stimulants is far thinner.

In July 2026 the Southern Nevada Health District presented findings to the Public Health Advisory Board covering January 2023 to May 2026. Two things stood out. Nevada’s overdose deaths fell only 2.2% over that period against a 15.9% decline across the rest of the country — the crisis here is easing far more slowly than nationally. And while fentanyl was the most commonly reported substance among respondents, about 95% of those who used fentanyl also reported using methamphetamine.

That last number matters more for treatment decisions than it first appears:

• For opioid dependence — fentanyl, heroin, prescription opioids, methadone and buprenorphine — ibogaine has the most support, principally its ability to interrupt withdrawal. See ibogaine for opioid dependence.
• For methamphetamine and other stimulants, the published evidence is considerably weaker, and there is no stimulant withdrawal syndrome for ibogaine to interrupt in the way it interrupts opioid withdrawal. See ibogaine and methamphetamine.
• For someone using both — which describes most fentanyl users in Southern Nevada — ibogaine may resolve the opioid half of the problem and leave the stimulant half largely untouched. Any clinic that does not raise this with you is not being straight.

We would rather tell a Las Vegas family that ibogaine addresses only part of their situation than take an enquiry we cannot honestly serve.

What About Gambling Addiction?

Ask carefully, and be sceptical of a confident answer. Las Vegas produces more gambling-related harm than anywhere else in the country, but ibogaine’s evidence for behavioural addictions is anecdotal — case reports and clinic accounts, not trials.

The theory people cite is that ibogaine acts on reward and habit circuitry rather than on a specific drug, so a compulsion without a substance might respond. That is a plausible mechanism, not a demonstrated result. There is no randomised trial of ibogaine for gambling disorder, and we are not going to imply there is.

If gambling is the primary problem, the honest ranking is that established treatments with an actual evidence base — cognitive behavioural therapy, the Nevada Council on Problem Gambling’s referral network, and peer support — should be exhausted first. Our page on ibogaine and behavioural addictions sets out what is and is not known.

What Happens Before You Travel?

Screening comes first. Ibogaine affects heart rhythm, so clinics require an ECG and bloodwork, a full medication review and a medical history before accepting anyone. Some people are screened out — and being told no is the system working.

• Initial conversation — what you are treating, what you have tried, current medications and doses.
• Medical screening — ECG, liver and kidney panels, electrolytes. Some medications, particularly certain antidepressants and long-acting opioids, need a supervised taper well beforehand.
• Clinic matching — facilities whose medical model fits the presentation, not whichever has a bed.
• Treatment — most programmes run seven to ten days.
• Integration — the part that determines whether the result holds. See integration therapy after ibogaine.

If you are in acute withdrawal or crisis right now, call 988 or 911. Ibogaine requires preparation and cannot be accessed on an emergency timeline.

Getting from Las Vegas to a Mexican Clinic

Harry Reid International Airport is one of the better-connected airports in the western United States for reaching Mexico, and Las Vegas patients generally have shorter journeys than most of the country. Baja California clinics near Tijuana and Rosarito are the closest option; Cancún carries the largest concentration of established ibogaine clinics and takes longer. Airline schedules change seasonally, so we check current routing with you rather than printing a flight time that goes stale.

Travel time is the least important variable anyway. Programme length, whether a physician is on site overnight, what screening is required before you fly, and whether integration is included matter far more to the outcome.

What Does Treatment Cost for Nevada Patients?

Between $5,000 and $15,000, depending on length of stay and facility. Insurance does not cover it, because ibogaine is Schedule I in the United States. Budget separately for flights and for integration support afterwards.

The range reflects real differences: programme length, whether a physician is on site around the clock, the level of cardiac monitoring, private versus shared accommodation, and whether integration is bundled. A very low price usually means fewer medical staff, which is the wrong place to economise.

What Psychedelic Connect Does

We are a treatment advisory service, not a clinic. We do not administer ibogaine and we do not own a facility. We help you work out whether ibogaine is reasonable in your specific case, and if it is, which clinic fits.

We visit the clinics we recommend — we look at medical staffing, monitoring equipment, what happens overnight, and what the facility does when something goes wrong. We are guided by people who get it, including clinicians and people who have been through this themselves. Our clinical content is reviewed by Christopher Diviaio, LCSW.

Resources in Las Vegas and Clark County:

• SAMHSA National Helpline: (800) 662-4357 — 24/7 treatment referral (samhsa.gov)
• 988 Suicide & Crisis Lifeline: call or text 988
• Veterans Crisis Line: 988, then Press 1
• Nevada Problem Gamblers HelpLine: (800) 522-4700 — 24/7, confidential

Consultation — Call Today

If you are in Las Vegas, Henderson, North Las Vegas, Summerlin or anywhere in Clark County, call (866) 435-7057 to talk with a patient coordinator. You can also start with our online form and we will follow up within one business day.

Medical Disclaimer: Psychedelic Connect is a treatment advisory service. We do not provide medical advice. Ibogaine treatment involves serious medical considerations including cardiac risks. Always consult a qualified medical professional before pursuing any treatment.

Frequently Asked Questions — Ibogaine Treatment, Las Vegas and Nevada

Is ibogaine legal in Nevada?
No. Ibogaine is a Schedule I controlled substance under federal law and Nevada has not created a state exemption. Possession is illegal and no Nevada clinic can administer it. Assembly Bill 378 (2025) would have created a supervised pilot programme for veterans and first responders, but it died in the Committee on Ways and Means with no final passage vote. Legal, medically supervised treatment is available at clinics in Mexico.

When could Nevada legalise ibogaine treatment?
Not before 2027 at the earliest. Nevada’s legislature holds regular sessions only in odd-numbered years, so there was no regular 2026 session and the next convenes in February 2027. Even if a successor to AB 378 passed then, regulations, approved clinics and approved practitioners would follow after that. Treat any specific date you are offered as speculation.

Does ibogaine work for methamphetamine addiction?
The evidence is much weaker than for opioids, and this matters in Southern Nevada, where about 95% of people who use fentanyl also report using methamphetamine. Ibogaine’s best-documented effect is interrupting opioid withdrawal, and there is no equivalent stimulant withdrawal for it to interrupt. For someone using both, it may address the opioid half and leave the stimulant half largely untouched.

Can ibogaine treat gambling addiction?
There is no randomised trial of ibogaine for gambling disorder — only case reports and clinic accounts. The proposed mechanism, that ibogaine acts on reward and habit circuitry rather than a specific substance, is plausible but unproven. If gambling is the primary problem, established treatments with a real evidence base should come first, and the Nevada Problem Gamblers HelpLine on (800) 522-4700 is the place to start.

Are there programmes for Nevada veterans?
Yes. Several clinics in our network run protocols built around combat-related PTSD, TBI and co-occurring substance use, and some pair ibogaine with 5-MeO-DMT for trauma processing. Veterans and first responders were also the population AB 378 was written for. See ibogaine for veterans.

How dangerous is ibogaine?
It carries real cardiac risk, which is why legitimate clinics require an ECG and bloodwork beforehand and why a facility without a physician on site should be ruled out. Published evidence for opioid dependence is promising but limited — mostly observational studies with small numbers and no control group. Anyone who tells you the risk is negligible, or that the evidence is settled, is overselling it.

Psychedelic Connect · (866) 435-7057 · contact@psychedelic-connect.com

Published 11 September 2026 · Last updated 11 September 2026 · Clinical review: Christopher Diviaio, LCSW